FDA Approves Sarclisa® for Relapsed Refractory Multiple Myeloma
Lung Cancer Screening Rates Still Low, CDC Reports
CAP Opens Comment Period for MMR/MSI Testing Draft Recommendations
ACCC Joins Coalition Letter Urging Inclusion of H.R. 913 in Healthcare Extenders Package
CMS Issues Proposed Changes to Medicare Advantage & Part D
CMS to Host MIPS Value Pathway Webinar
FDA Expands Coverage of Diagnostic Testing Using NGS
GAO Report Calls for More Oversight of 340B Hospital Eligibility
Update to ASCO/CAP Guideline on ER and PgR Testing in Breast Cancer
FDA Approves Avapritinib for GIST Subset
ACS Report Finds Largest One-Year Drop in Cancer Deaths
FDA Approves Pembrolizumab for Treatment of Subset of Bladder Cancer Patients
FDA Approves Enhertu for Previously Treated Unresectable or Metastatic HER2+ Breast Cancer
ACCC Responds to CMMI RFI on Oncology Care First Model
FDA Approves Padcev (enfortumab vedotin-ejfv) for Advanced Urothelial Cancer
Trump Administration Issues Proposed Rule on Importation of Prescription Drugs
FDA Approves Enzalutamide for Metastatic Castration-Sensitive Prostate Cancer
CMS Extends Open Enrollment Deadline to Dec. 18
Senate Confirms Dr. Stephen Hahn as U.S. FDA Commissioner
Inside Health Policy Reports: CMS to Repay Hospitals for 2019 Site-Neutral Pay Cut
ASTRO Issues New Clinical Guideline for Radiation Therapy for BCC and cSCC
NCCN Updates Genetic Testing Guidelines for Assessing Breast, Ovarian, and Pancreatic Cancer Risk
FDA Approves Atezolizumab + Chemotherapy for Metastatic Non-Squamous NSCLC
ACCC Dec. 5 Webinar on CY2020 Medicare Final Payment Rules
FDA Approves Reblozyl for Anemia in Adults with Beta Thalassemia
FDA Approves New Treatment Option for CLL Under International Collaboration
CMS Plans Dec. 3 Call on Hospital Price Transparency Final Rule
CMS Issues Rules on Price Transparency for Hospitals and Health Insurance Issuers
FDA Grants Accelerated Approval to Zanubrutinib for Mantle Cell Lymphoma
ACP Issues New Guidance for Colorectal Cancer Screening
